1. Why Neoplasms Matter Clinically

Neoplasms are clinically important mainly because they cause:

• Morbidity – illness, disability, symptoms, poor quality of life
• Mortality – death

So, when we talk about cancer clinically, we care less about the histology “beauty” and more about what the tumor is doing to the patient.

• Malignant tumors are generally more dangerous.
• But benign tumors are not automatically harmless:
• They can compress vital structures.
• They can produce hormones.
• They can still cause serious morbidity and even mortality.

Memory idea:

• “Cancer hurts by what it does, not just what it is.”
• “Benign ≠ Harmless.”

2. Five Main Ways Tumors Cause Problems

You can group the clinical effects as:

L-F-B-R-C = Location, Function, Bleeding, Rupture, Cachexia

1. Location and Impingement
2. Functional Activity (hormones, paraneoplastic syndromes)
3. Bleeding and Infection from Ulceration
4. Rupture or Infarction
5. Cachexia (wasting)

2.1 Location and Impingement

Tumor location is often more important than size. Even very small tumors can be catastrophic if they are in critical sites.

Examples

• Pituitary adenoma
• A 1 cm pituitary adenoma can compress and destroy the surrounding normal pituitary gland.
• Result → hypopituitarism (loss of normal pituitary hormone function).
• Renal artery leiomyoma
• A 0.5 cm benign smooth muscle tumor in the renal artery wall can narrow the vessel.
• Result → renal ischemia and hypertension.
• Common bile duct carcinoma
• A small carcinoma in the common bile duct can block bile flow.
• Result → fatal biliary obstruction (jaundice, liver failure, sepsis risk).

Memory ideas:

• “Small size, big trouble.”
• “Tiny pituitary tumor = hormone blackout.”
• “Half cm tumor = high pressure.”
• “Tiny bile tumor = big blockage.”

2.2 Functional Activity (Hormonal and Paraneoplastic)

Some tumors, especially of endocrine glands, cause symptoms because they secrete hormones or hormone-like substances.

Endocrine Tumors

• Tumors (benign or malignant) of endocrine glands can produce hormones.
• Well-differentiated benign endocrine tumors are more likely to show hormone activity than poorly differentiated carcinomas.

Examples

• Pancreatic islet (beta-cell) tumors
• Adenomas or carcinomas of pancreatic β-cells produce insulin.
• Excess insulin → hyperinsulinism, which can be severe and even fatal due to recurrent hypoglycemia.
• Adrenal cortex tumors
• Adenomas or carcinomas of the adrenal cortex may produce steroids.
• Overproduction of aldosterone → sodium retention, hypertension, and hypokalemia.

Memory idea:

• “Endocrine tumors talk in hormones.”

(Paraneoplastic syndromes are another type of “functional” effect and are covered separately in section 4.)

2.3 Bleeding and Infection from Ulceration

When tumors grow on or near mucosal surfaces, they can ulcerate.

• Ulceration leads to:
• Bleeding
• Secondary infection

In the gastrointestinal tract, if a tumor protrudes into the lumen, it can be pulled along by peristalsis:

• This may cause:
• Intussusception (one part of bowel telescopes into another)
• Obstruction
• Infarction (ischemic necrosis of bowel)

2.4 Rupture or Infarction

Some tumors are dangerous because they can:

• Rupture:
• For example, tumors in solid organs or near vessels can bleed if they rupture.
• Undergo infarction:
• If the tumor outgrows its blood supply or twists, it can infarct, causing pain, hemorrhage, and systemic effects.

(Your source grouped “rupture/infarction” as one of the five main clinical mechanisms without detailed standalone examples, but it is an important category.)

2.5 Cancer Cachexia

Cancer cachexia is a characteristic wasting syndrome seen in many patients with advanced malignancy.

Definition

Cancer cachexia is:

• Progressive loss of:
• Fat mass
• Lean body mass (muscle)
• Associated with:
• Weakness
• Anorexia
• Anemia

So it is not just “weight loss” – it is global wasting with functional decline.

Cause: Cytokines, Not Calories

• Cachexia is not simply due to the tumor “stealing calories”.
• It is largely driven by soluble factors (cytokines) produced by:
• Tumor cells
• Host immune cells (e.g., macrophages)

The key cytokine is:

• TNF (tumor necrosis factor) – often called “cachectin”
• Produced by macrophages and tumor cells.
• Mechanisms:
• Suppresses appetite
• Inhibits lipoprotein lipase → reduces fat storage and promotes fat breakdown, but in a way that contributes to wasting rather than efficient fuel use.

Memory ideas:

• “Cachexia = cancer wasting.”
• “Cytokines, not calories.”
• “TNF = Thinness Factor.”
• “TNF: no appetite, no fat storage.”

Metabolic Changes: Cancer vs Starvation

• Cancer cachexia:
• Basal metabolic rate is increased despite poor intake.
• Simple starvation:
• Body decreases metabolic rate as an adaptive response.

Memory idea:

• “Cancer burns, starvation slows.”

Treatment

• There is no fully satisfactory medical treatment for cachexia.
• The only real “cure” is removal of the tumor (if possible).
• Supportive nutrition alone does not reverse cachexia if the tumor remains.

Memory idea:

• “Only cure = cut the cancer.”

3. Paraneoplastic Syndromes (PNS)

3.1 Definition and Importance

Paraneoplastic syndromes are:

• Symptom complexes in cancer patients that cannot be explained by:
• Local tumor effects
• Distant metastases
• Native hormone production of the tissue

Instead, PNS are due to tumor-derived factors like ectopic hormones, hormone-like peptides, or immune-mediated effects.

They occur in about 10–15% of cancer patients.

Why Recognizing PNS Is Important

1. They may be the earliest sign of an otherwise occult (hidden) neoplasm.
2. They can cause serious illness or even death.
3. They may mimic metastatic disease, making staging and treatment decisions confusing if not recognized.

So, PNS are clinically important markers and can change how you interpret symptoms.

3.2 Tumors Commonly Associated with PNS

Paraneoplastic syndromes are especially associated with:

• Lung cancers
• Breast cancers
• Hematologic malignancies (e.g., leukemias, lymphomas)

Memory idea:

• “PNS loves lungs, breast, blood.”

3.3 The “Big Three” Paraneoplastic Syndromes

Three classic, high-yield PNS:

1. Hypercalcemia
2. Cushing syndrome
3. Nonbacterial thrombotic endocarditis (NBTE) and other clotting issues

Memory idea:

• “Three big PNS = Ca²⁺, Cortisol, Clots.”

3.3.1 Hypercalcemia

• One of the most common paraneoplastic endocrine syndromes.
• Mechanism:
• Tumor secretes PTHrP (parathyroid hormone–related protein).
• May also involve TGF-α and active vitamin D.
• Important distinction:
• Hypercalcemia due to skeletal metastases (bone destruction) is not paraneoplastic – it is a direct effect of bone involvement.

Memory idea:

• “Fake PTH from tumor.”

3.3.2 Cushing Syndrome

• A paraneoplastic Cushing syndrome occurs when tumors secrete ectopic ACTH or ACTH-like peptides.
• Classic example:
• Small cell carcinoma of the lung producing ectopic ACTH.
• Leads to ↑ cortisol with all the usual Cushing features (central obesity, muscle wasting, hypertension, glucose intolerance, etc.).

3.3.3 Clotting Abnormalities

• Tumors can create a hypercoagulable state, causing:
• Venous thrombosis
• Nonbacterial thrombotic endocarditis (NBTE) – sterile vegetations on cardiac valves.
• These phenomena could lead to emboli and serious complications.

3.4 Other Paraneoplastic Manifestations

• In some lung carcinomas, patients develop:
• Clubbing of the fingers
• Hypertrophic osteoarthropathy (painful enlargement and periostitis of long bones)

This is another example of paraneoplastic changes of the skeleton.

• Many other paraneoplastic syndromes exist (neurologic, dermatologic, hematologic, etc.), and are best studied with specific organ cancers.

4. Summary Comparison (Concept Map)

Effects of Tumors on the Host

• Core concept: tumors cause clinical disease via location, function, bleeding, rupture, cachexia.
• Location/impingement:
• Small tumor, big effect (pituitary adenoma, renal artery leiomyoma, bile duct carcinoma).
• Functional activity:
• Endocrine tumors produce hormones (insulin, aldosterone).
• Ulceration:
• Bleeding, infection, obstruction, intussusception, infarction.
• Rupture/infarction:
• Hemorrhage, acute abdomen, systemic shock.
• Cachexia:
• Cytokine-driven wasting; TNF central; increased metabolic rate; only real “treatment” is tumor removal.

Cancer Cachexia

• Wasting of fat and lean mass with weakness, anorexia, anemia.
• Caused by cytokines (especially TNF) from tumor and host.
• Metabolic rate increased (contrast with starvation).
• Not due to simple “calorie theft.”

Paraneoplastic Syndromes

• Remote effects not due to local/distant spread or native hormones.
• Occur in ~10–15% of cancer patients.
• Important because they may be early, serious, and mimic metastases.
• Common ones:
• Hypercalcemia (PTHrP ± TGF-α, active vitamin D).
• Cushing syndrome (ectopic ACTH from small cell lung).
• Thrombotic phenomena (venous thrombosis, NBTE).
• Clubbing and hypertrophic osteoarthropathy in lung cancer.
• Often associated with lung, breast, and hematologic malignancies.